Market Currents
The FTC will require Novartis (NVS +0.3%) to give up its marketing rights to four topical skin...
-
Monday, July 16, 2012, 1:12 PM ETThe FTC will require Novartis (NVS +0.3%) to give up its marketing rights to four topical skin care medications as part of its $1.5B acquisition of Fougera. Novartis has an agreement for the treatments with Tolmar. (FTC PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
